Male sexual dysfunction after pelvic fracture.
Michael Metze, Andreas H Tiemann, Christoph Josten
https://pubmed.ncbi.nlm.nih.gov/17693842/Actively Recruiting
Led by Wake Forest University Health Sciences · Updated on 2026-10-23
200
Participants Needed
1
Research Sites
104 weeks
Total Duration
Researchers are collecting data from patients who have experienced pelvic and acetabular fractures to understand how their function and self-reported health outcomes change over time. This study includes patients treated with surgery or without surgery to answer important questions about different treatment approaches. Participants are grouped by the type of fracture they haveeither pelvic ring fractures or acetabular fractures. The study observes both surgical and nonsurgical treatments as they happen in usual care, without assigning treatments. Data is gathered prospectively to analyze recovery trajectories and outcomes. During the study, participants will provide information through performance tests like the 10 meter walk, Five Time Sit to Stand, and Timed Up and Go tests at multiple times up to 24 months after injury. Patient-reported outcomes using the NIH PROMIS tool and healing progress will also be tracked. Researchers will assess return to work and activities, complications, and changes in health status over two years.
CONDITIONS
Pelvic and Acetabular Fracture: A Prospective Observational Study
C
Christine Churchill, MA
E
Erica Grochowski, MS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Wake Forest University Health Sciences
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 24 months
Participants will be observed over time without assigned treatments. Researchers collect performance tests and patient-reported outcomes to track recovery.
Assessments at baseline, 3, 6, 12, and 24 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Michael Metze, Andreas H Tiemann, Christoph Josten
https://pubmed.ncbi.nlm.nih.gov/17693842/Demetrios Demetriades, Marios Karaiskakis, Konstantinos Toutouzas...
https://pubmed.ncbi.nlm.nih.gov/12113532/Efstathios Katsoulis, Peter V Giannoudis
https://pubmed.ncbi.nlm.nih.gov/17092504/Cory A Collinge, Michael T Archdeacon, George LeBus
https://pubmed.ncbi.nlm.nih.gov/19571085/Martin F Hoffmann, Clifford B Jones, Debra L Sietsema
https://pubmed.ncbi.nlm.nih.gov/22278851/P Tornetta, J M Matta
https://pubmed.ncbi.nlm.nih.gov/8769450/James Min-Leong Wong, Andrew Bucknill
https://pubmed.ncbi.nlm.nih.gov/24360668/M C Reilly, D M Zinar, J M Matta
https://pubmed.ncbi.nlm.nih.gov/8769433/T Pohlemann, A Gänsslen, O Schellwald...
https://pubmed.ncbi.nlm.nih.gov/8915200/Tomas Borg, Per Berg, Kerstin Fugl-Meyer...
https://pubmed.ncbi.nlm.nih.gov/20005513/Wake Forest University Health Sciences
Lead Sponsor